Enhancing the efficacy of viral vector blood-stage malaria vaccines
<p>Replication-deficient adenovirus (Ad) and modified vaccinia virus Ankara (MVA) vectors expressing single Plasmodium falciparum antigens can induce potent T cell and antibody responses and have entered clinical testing using a heterologous prime-boost immunisation approach (Ad_MVA). This the...
Автор: | Forbes, E |
---|---|
Інші автори: | Hill, A |
Формат: | Дисертація |
Мова: | English |
Опубліковано: |
2011
|
Предмети: |
Схожі ресурси
Схожі ресурси
-
Pre-clinical development of viral vectored transmission-blocking malaria vaccines
за авторством: Kapulu, MC
Опубліковано: (2014) -
Developing novel blood-stage malaria vaccines
за авторством: Douglas, AD
Опубліковано: (2015) -
Malaria pre-erythrocytic stage vaccines: targeting antigen combinations
за авторством: Bauza, K
Опубліковано: (2012) -
Towards improved blood-stage malaria vaccines: characterising the underlying immunogenicity of vaccine adjuvants and vectors
за авторством: de Cassan, S
Опубліковано: (2011) -
Analysis of b cell responses to blood-stage malaria antigens in humans following immunization with candidate vaccines and controlled human malaria infection
за авторством: Elias, SC
Опубліковано: (2014)